Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Short-Term Debt repayments (2021 - 2024)

Historic Short-Term Debt repayments for Harvard Bioscience (HBIO) over the last 4 years, with Q2 2024 value amounting to $2.0 million.

  • Harvard Bioscience's Short-Term Debt repayments fell 3050.85% to $2.0 million in Q2 2024 from the same period last year, while for Mar 2025 it was $2.0 million, marking a year-over-year decrease of 7709.5%. This contributed to the annual value of $2.6 million for FY2024, which is 7671.23% down from last year.
  • As of Q2 2024, Harvard Bioscience's Short-Term Debt repayments stood at $2.0 million, which was down 3050.85% from $500000.0 recorded in Q1 2024.
  • In the past 5 years, Harvard Bioscience's Short-Term Debt repayments ranged from a high of $4.0 million in Q1 2021 and a low of -$1.8 million during Q4 2021
  • Moreover, its 4-year median value for Short-Term Debt repayments was $2.5 million (2023), whereas its average is $2.0 million.
  • Its Short-Term Debt repayments has fluctuated over the past 5 years, first skyrocketed by 19722.22% in 2022, then crashed by 8000.0% in 2024.
  • Harvard Bioscience's Short-Term Debt repayments (Quarter) stood at -$1.8 million in 2021, then surged by 197.22% to $1.8 million in 2022, then soared by 42.86% to $2.5 million in 2023, then fell by 18.0% to $2.0 million in 2024.
  • Its last three reported values are $2.0 million in Q2 2024, $500000.0 for Q1 2024, and $2.5 million during Q4 2023.